Empower Gene Table by Panel

Panorama Sample Report

ACOG Practice Bulletin: Screening for Fetal Chromosomal Abnormalities

Combining the use of a fetal fraction based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for feta

Benn et al. 2019 J Genet Couns.

Screening for 22q11.2 deletion syndrome by two non-invasive prenatal testing methodologies: A case with discordant results

Lo et al. 2019 J. Obstet. Gyn.

Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomy 13, 18, and triploidy in women with low cell-fr

McKanna et al. 2018 Ultrasound Obstet. Gynecol.

Factors Associated with Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing

Benn et al. 2018 Obstet. Gyn.

Pregnancy outcomes from more than 1,800 in vitro fertilization cycles using 24‑chromosome single-nucleotide polymorphism-based preimplantati

Simon et al 2018 Fertil. Steril.

Validation of a SNP-based non-invasive prenatal test to detect the fetal 22q11.2 deletion in maternal plasma samples

Ravi et al. 2018 PLoS One

Validation of a SNP-based NIPT in twin gestations: determination of zygosity, individual fetal sex, and fetal aneuploidy

Norwitz et al. 2019 J. Clin. Med.

Clinical Experience with a Single-Nucleotide Polymorphism-Based Noninvasive Prenatal Test for Five Clinically Significant Microdeletions

Martin et al. 2017 Clin. Genet.

Single-nucleotide polymorphism microarray detects molar pregnancies in 3% of miscarriages

Maisenbacher et al. 2019 Fertil. Steril.

Pediatric Healthcare Costs for Patients with 22q11.2 Deletion Syndrome

Benn et al. 2017 Mol. Genet. Genom. Med.

Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome Measures

DiNonno et al. 2019 J. Clin. Med.